| IOD | Name: | IODIDE ION | Formula: | I | SMILES: | [I-] | InChi: | InChI=1S/HI/h1H/p-1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | iodide |
|
| IOY | Name: | P-IODO-D-PHENYLALANINE | Formula: | C9 H10 I N O2 | SMILES: | Ic1ccc(cc1)CC(C(=O)O)N | InChi: | InChI=1S/C9H10INO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m1/s1 | Synonyms: | 4-IODOPHENYLALANINE | Definition date: | 2004-09-14 | Last modified: | 2024-09-27 | Identifier: | 4-iodo-D-phenylalanine |
|
| IP8 | Name: | Isopentenyl phosphate | Formula: | C5 H11 O4 P | SMILES: | O=P(OCCC(=C)C)(O)O | InChi: | InChI=1S/C5H11O4P/c1-5(2)3-4-9-10(6,7)8/h1,3-4H2,2H3,(H2,6,7,8) | Synonyms: | 3-methylbut-3-en-1-yl dihydrogen phosphate | Definition date: | 2009-10-21 | Last modified: | 2024-09-27 | Identifier: | 3-methylbut-3-en-1-yl dihydrogen phosphate |
|
| IPD | Name: | D-MYO-INOSITOL-1-PHOSPHATE | Formula: | C6 H11 O9 P | SMILES: | O=P([O-])([O-])OC1C(O)C(O)C(O)C(O)C1O | InChi: | InChI=1S/C6H13O9P/c7-1-2(8)4(10)6(5(11)3(1)9)15-16(12,13)14/h1-11H,(H2,12,13,14)/p-2/t1-,2-,3+,4-,5-,6-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate |
|
| IPG | Name: | N-ISOPROPYL GLYCINE | Formula: | C5 H11 N O2 | SMILES: | O=C(O)CNC(C)C | InChi: | InChI=1S/C5H11NO2/c1-4(2)6-3-5(7)8/h4,6H,3H2,1-2H3,(H,7,8) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-(1-methylethyl)glycine |
|
| IPI | Name: | 3-methylbutylphosphonic acid | Formula: | C5 H13 O3 P | SMILES: | CC(C)CC[P](O)(O)=O | InChi: | InChI=1S/C5H13O3P/c1-5(2)3-4-9(6,7)8/h5H,3-4H2,1-2H3,(H2,6,7,8) | Synonyms: | isoamylphosphonic acid | Definition date: | 2011-01-21 | Last modified: | 2024-09-27 | Identifier: | 3-methylbutylphosphonic acid |
|
| IPP | Name: | (P-IODOPHENYLACETYLAMINO)METHYLPHOSPHINIC ACID | Formula: | C9 H11 I N O3 P | SMILES: | Ic1ccc(cc1)CC(=O)NCP(=O)O | InChi: | InChI=1S/C9H11INO3P/c10-8-3-1-7(2-4-8)5-9(12)11-6-15(13)14/h1-4,15H,5-6H2,(H,11,12)(H,13,14) | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (R)-({[(4-iodophenyl)acetyl]amino}methyl)phosphinic acid |
|
| IQ8 | Name: | N-(2-acetamidoethyl)-4-(4,5-dihydro-1,3-thiazol-2-yl)benzamide | Formula: | C14 H17 N3 O2 S | SMILES: | CC(=O)NCCNC(=O)c1ccc(cc1)C2=NCCS2 | InChi: | InChI=1S/C14H17N3O2S/c1-10(18)15-6-7-16-13(19)11-2-4-12(5-3-11)14-17-8-9-20-14/h2-5H,6-9H2,1H3,(H,15,18)(H,16,19) | Definition date: | 2022-07-08 | Last modified: | 2024-09-27 | Release date: | 2023-09-27 | Identifier: | ~{N}-(2-acetamidoethyl)-4-(4,5-dihydro-1,3-thiazol-2-yl)benzamide |
|
| 3S2 | Name: | [(2S,3R)-2-formyl-1-{[4-(methylamino)butyl]carbamoyl}pyrrolidin-3-yl]sulfamic acid | Formula: | C11 H22 N4 O5 S | SMILES: | O=C(NCCCCNC)N1C(C=O)C(NS(=O)(=O)O)CC1 | InChi: | InChI=1S/C11H22N4O5S/c1-12-5-2-3-6-13-11(17)15-7-4-9(10(15)8-16)14-21(18,19)20/h8-10,12,14H,2-7H2,1H3,(H,13,17)(H,18,19,20)/t9-,10-/m1/s1 | Definition date: | 2011-05-17 | Last modified: | 2024-09-27 | Identifier: | [(2S,3R)-2-formyl-1-{[4-(methylamino)butyl]carbamoyl}pyrrolidin-3-yl]sulfamic acid |
|
| IRK | Name: | (1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid | Formula: | C21 H37 N3 O8 S | SMILES: | CC(C)CC(NC(=O)OCC1CC1CCC)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C21H37N3O8S/c1-4-5-13-9-15(13)11-32-21(28)24-16(8-12(2)3)19(26)23-17(20(27)33(29,30)31)10-14-6-7-22-18(14)25/h12-17,20,27H,4-11H2,1-3H3,(H,22,25)(H,23,26)(H,24,28)(H,29,30,31)/t13-,14-,15-,16-,17-,20+/m0/s1 | Definition date: | 2022-01-27 | Last modified: | 2024-09-27 | Release date: | 2022-03-02 | Identifier: | (1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-2-{[N-({[(1R,2S)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucyl]amino}propane-1-sulfonic acid |
|
| IRQ | Name: | lambda-{1-([2,2'-bipyridin]-5-ylmethyl)pyrrolidine-2,5-dione}bis[2-(2,4-difluorophenyl)pyridine)]iridium(III) | Formula: | C37 H25 F4 Ir N5 O2 | SMILES: | Fc1cc(F)c(c([Ir+3]c2cc(F)cc(F)c2c3ccccn3)c1)c4ccccn4.O=C5CCC(=O)N5Cc6ccc(nc6)c7ccccn7 | InChi: | InChI=1S/C15H13N3O2.2C11H6F2N.Ir/c19-14-6-7-15(20)18(14)10-11-4-5-13(17-9-11)12-3-1-2-8-16-12 | Definition date: | 2022-08-27 | Last modified: | 2024-09-27 | Release date: | 2023-03-15 |
|
| IRR | Name: | N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[(1R,2R)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucinamide | Formula: | C21 H35 N3 O5 | SMILES: | CC(C)CC(NC(=O)OCC1CC1CCC)C(=O)NC(CC1CCNC1=O)C=O | InChi: | InChI=1S/C21H35N3O5/c1-4-5-14-9-16(14)12-29-21(28)24-18(8-13(2)3)20(27)23-17(11-25)10-15-6-7-22-19(15)26/h11,13-18H,4-10,12H2,1-3H3,(H,22,26)(H,23,27)(H,24,28)/t14-,15+,16+,17+,18+/m1/s1 | Definition date: | 2022-01-27 | Last modified: | 2024-09-27 | Release date: | 2022-02-09 | Identifier: | N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-N~2~-({[(1R,2R)-2-propylcyclopropyl]methoxy}carbonyl)-L-leucinamide |
|
| 3TR | Name: | 3-AMINO-1,2,4-TRIAZOLE | Formula: | C2 H4 N4 | SMILES: | n1c(nnc1)N | InChi: | InChI=1S/C2H4N4/c3-2-4-1-5-6-2/h1H,(H3,3,4,5,6) | Synonyms: | AMITROLE | Definition date: | 2004-06-09 | Last modified: | 2024-09-27 | Identifier: | 1H-1,2,4-triazol-3-amine |
|
| IRW | Name: | (1S,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid | Formula: | C25 H37 N3 O9 S | SMILES: | COc1ccc(cc1)C1CC1COC(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C(O)S(=O)(=O)O | InChi: | InChI=1S/C25H37N3O9S/c1-14(2)10-20(23(30)27-21(24(31)38(33,34)35)12-16-8-9-26-22(16)29)28-25(32)37-13-17-11-19(17)15-4-6-18(36-3)7-5-15/h4-7,14,16-17,19-21,24,31H,8-13H2,1-3H3,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35)/t16-,17-,19-,20-,21-,24-/m0/s1 | Definition date: | 2022-01-27 | Last modified: | 2024-09-27 | Release date: | 2022-02-09 | Identifier: | (1S,2S)-1-hydroxy-2-{[N-({[(1R,2R)-2-(4-methoxyphenyl)cyclopropyl]methoxy}carbonyl)-L-leucyl]amino}-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid |
|
| IRY | Name: | [(2~{S})-2,3-bis(oxidanyl)propyl] 8-hexylselanyloctanoate | Formula: | C17 H34 O4 Se | SMILES: | CCCCCC[Se]CCCCCCCC(=O)OC[CH](O)CO | InChi: | InChI=1S/C17H34O4Se/c1-2-3-4-9-12-22-13-10-7-5-6-8-11-17(20)21-15-16(19)14-18/h16,18-19H,2-15H2,1H3/t16-/m0/s1 | Definition date: | 2023-08-03 | Last modified: | 2024-09-27 | Release date: | 2024-05-15 | Identifier: | [(2~{S})-2,3-bis(oxidanyl)propyl] 8-hexylselanyloctanoate |
|
| IRZ | Name: | N~2~-({[(1R,2R)-2-(3-chlorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C24 H32 Cl N3 O5 | SMILES: | Clc1cccc(c1)C1CC1COC(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C=O | InChi: | InChI=1S/C24H32ClN3O5/c1-14(2)8-21(23(31)27-19(12-29)10-16-6-7-26-22(16)30)28-24(32)33-13-17-11-20(17)15-4-3-5-18(25)9-15/h3-5,9,12,14,16-17,19-21H,6-8,10-11,13H2,1-2H3,(H,26,30)(H,27,31)(H,28,32)/t16-,17-,19-,20-,21-/m0/s1 | Definition date: | 2022-01-27 | Last modified: | 2024-09-27 | Release date: | 2022-06-22 | Identifier: | N~2~-({[(1R,2R)-2-(3-chlorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
| 3TY | Name: | 3-[(3E)-3-(BENZYLHYDRAZONO)-4-HYDROXY-6-OXOCYCLOHEXA-1,4-DIEN-1-YL]-L-ALANINE | Formula: | C16 H17 N3 O4 | SMILES: | O=C2C=C(O)/C(=N/NCc1ccccc1)C=C2CC(C(=O)O)N | InChi: | InChI=1S/C16H17N3O4/c17-12(16(22)23)6-11-7-13(15(21)8-14(11)20)19-18-9-10-4-2-1-3-5-10/h1-5,7-8,12,18,21H,6,9,17H2,(H,22,23)/b19-13+/t12-/m0/s1 | Definition date: | 2004-08-11 | Last modified: | 2024-09-27 | Identifier: | 3-[(3E)-3-(benzylhydrazono)-4-hydroxy-6-oxocyclohexa-1,4-dien-1-yl]-L-alanine |
|
| 3U0 | Name: | 2-[4-(carbamimidamidomethyl)phenyl]ethanoic acid | Formula: | C10 H13 N3 O2 | SMILES: | NC(=N)NCc1ccc(CC(O)=O)cc1 | InChi: | InChI=1S/C10H13N3O2/c11-10(12)13-6-8-3-1-7(2-4-8)5-9(14)15/h1-4H,5-6H2,(H,14,15)(H4,11,12,13) | Synonyms: | 2-[4-[(diaminomethylideneamino)methyl]phenyl]acetic acid | Definition date: | 2014-10-24 | Last modified: | 2024-09-27 | Release date: | 2022-10-19 | Identifier: | 2-[4-(carbamimidamidomethyl)phenyl]ethanoic acid |
|
| IS4 | Name: | (7~{S})-2-(4-bromanyl-3,5-dimethoxy-phenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide | Formula: | C23 H30 Br N5 O4 | SMILES: | CCC(=O)N1CCC(CC1)[CH]2CCNc3n2nc(c4cc(OC)c(Br)c(OC)c4)c3C(N)=O | InChi: | InChI=1S/C23H30BrN5O4/c1-4-18(30)28-9-6-13(7-10-28)15-5-8-26-23-19(22(25)31)21(27-29(15)23)14-11-16(32-2)20(24)17(12-14)33-3/h11-13,15,26H,4-10H2,1-3H3,(H2,25,31)/t15-/m0/s1 | Definition date: | 2022-07-14 | Last modified: | 2024-09-27 | Release date: | 2023-05-17 | Identifier: | (7~{S})-2-(4-bromanyl-3,5-dimethoxy-phenyl)-7-(1-propanoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide |
|
| 3U2 | Name: | N-[(1S,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methylcyclohexyl]benzamide | Formula: | C14 H19 N O4 | SMILES: | O=C(NC1C(C(O)C(O)C(O)C1)C)c2ccccc2 | InChi: | InChI=1S/C14H19NO4/c1-8-10(7-11(16)13(18)12(8)17)15-14(19)9-5-3-2-4-6-9/h2-6,8,10-13,16-18H,7H2,1H3,(H,15,19)/t8-,10+,11-,12-,13+/m1/s1 | Definition date: | 2014-10-29 | Last modified: | 2024-09-27 | Release date: | 2014-11-12 | Identifier: | N-[(1S,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methylcyclohexyl]benzamide |
|
| 3U3 | Name: | N-[(1S,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methylcyclohexyl]acetamide | Formula: | C9 H17 N O4 | SMILES: | O=C(NC1C(C(O)C(O)C(O)C1)C)C | InChi: | InChI=1S/C9H17NO4/c1-4-6(10-5(2)11)3-7(12)9(14)8(4)13/h4,6-9,12-14H,3H2,1-2H3,(H,10,11)/t4-,6+,7-,8-,9+/m1/s1 | Definition date: | 2014-10-29 | Last modified: | 2024-09-27 | Release date: | 2014-11-05 | Identifier: | N-[(1S,2R,3R,4S,5R)-3,4,5-trihydroxy-2-methylcyclohexyl]acetamide |
|
| IS5 | Name: | N~2~-({[(1R,2R)-2-(3-fluorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide | Formula: | C24 H32 F N3 O5 | SMILES: | Fc1cccc(c1)C1CC1COC(=O)NC(CC(C)C)C(=O)NC(CC1CCNC1=O)C=O | InChi: | InChI=1S/C24H32FN3O5/c1-14(2)8-21(23(31)27-19(12-29)10-16-6-7-26-22(16)30)28-24(32)33-13-17-11-20(17)15-4-3-5-18(25)9-15/h3-5,9,12,14,16-17,19-21H,6-8,10-11,13H2,1-2H3,(H,26,30)(H,27,31)(H,28,32)/t16-,17-,19-,20-,21-/m0/s1 | Definition date: | 2022-01-27 | Last modified: | 2024-09-27 | Release date: | 2022-06-22 | Identifier: | N~2~-({[(1R,2R)-2-(3-fluorophenyl)cyclopropyl]methoxy}carbonyl)-N-{(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}-L-leucinamide |
|
| IS7 | Name: | 1,5-dimethyl-3~{H}-indol-2-one | Formula: | C10 H11 N O | SMILES: | CN1C(=O)Cc2cc(C)ccc12 | InChi: | InChI=1S/C10H11NO/c1-7-3-4-9-8(5-7)6-10(12)11(9)2/h3-5H,6H2,1-2H3 | Definition date: | 2020-05-05 | Last modified: | 2024-09-27 | Release date: | 2021-05-12 | Identifier: | 1,5-dimethyl-3~{H}-indol-2-one |
|
| IS9 | Name: | dimethylcarbamodithioic acid | Formula: | C3 H7 N S2 | SMILES: | CN(C)C(S)=S | InChi: | InChI=1S/C3H7NS2/c1-4(2)3(5)6/h1-2H3,(H,5,6) | Definition date: | 2023-08-03 | Last modified: | 2024-09-27 | Release date: | 2023-11-01 | Identifier: | dimethylcarbamodithioic acid |
|
| 3U7 | Name: | 4-{2,3-dichloro-4-[3-(1H-imidazol-2-yl)propanoyl]phenoxy}butanoic acid | Formula: | C16 H16 Cl2 N2 O4 | SMILES: | O=C(c1ccc(OCCCC(=O)O)c(Cl)c1Cl)CCc2nccn2 | InChi: | InChI=1S/C16H16Cl2N2O4/c17-15-10(11(21)4-6-13-19-7-8-20-13)3-5-12(16(15)18)24-9-1-2-14(22)23/h3,5,7-8H,1-2,4,6,9H2,(H,19,20)(H,22,23) | Definition date: | 2014-10-30 | Last modified: | 2024-09-27 | Release date: | 2015-05-20 | Identifier: | 4-{2,3-dichloro-4-[3-(1H-imidazol-2-yl)propanoyl]phenoxy}butanoic acid |
|